Skip to main content
Affluent Medical logo

Affluent Medical — Investor Relations & Filings

Ticker · AFME ISIN · FR0013333077 LEI · 969500N30CO4B5N2GN67 PA Manufacturing
Filings indexed 275 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country FR France
Listing PA AFME

About Affluent Medical

https://www.affluentmedical.com

Affluent Medical is a clinical-stage medical technology company that develops innovative, minimally invasive implants designed to restore essential physiological functions. The company's activities are concentrated in two primary therapeutic areas: structural heart disease and urology. It specifically addresses severe mitral valve insufficiency and urinary incontinence. The product pipeline, currently in clinical development, features three key devices: Kalios™, an adjustable annuloplasty ring for mitral valve repair; Epygon™, a biomimetic mitral valve for replacement procedures; and Artus™, an electronic artificial urinary sphincter for treating urinary incontinence. Affluent Medical's technologies are engineered to be adjustable and biomimetic, allowing for implantation via minimally invasive surgery and adaptation to both the patient's anatomy and the progression of their pathology.

Recent filings

Filing Released Lang Actions
Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 30.04.26.
Regulatory Filings Classification · 85% confidence The document is a press release disclosing the number of shares and total voting rights as of April 30, 2026, in compliance with French Commercial Code L.233-8 and AMF Regulation 223-16. It is a routine regulatory announcement rather than the filing of a full report, earnings release, voting results, or share issue. It does not represent a financial report itself but is a general compliance notification. Therefore, it falls under the general Regulatory Filings category (RNS).
2026-05-20 French
Carvolix : Nombre dactions composant le capital social et nombre total de droits de vote au 30.04.26.
Regulatory Filings Classification · 82% confidence The document is a short regulatory news release under French AMF rules disclosing the total number of shares and voting rights as of 30.04.26. It does not contain financial statements or constitute an interim/annual report; it’s simply a compliance announcement of share and voting rights counts. There is no specific category for “voting rights count” notice, so it falls under the general ‘‘Regulatory Filings’’ category (RNS).
2026-05-20 French
Carvolix Announces Positive Results of the Postmarketing Clinical Program Evaluating the TAVIPILOT AI Software.
Regulatory Filings
2026-05-04 English
Carvolix annonce des résultats positifs du programme clinique post-commercial évaluant le logiciel TAVIPILOT IA.
Regulatory Filings
2026-05-04 French
Carvolix Announces Positive Results of the Postmarketing Clinical Program Evaluating the TAVIPILOT AI Software.
Regulatory Filings
2026-05-04 English
Document d'enregistrement universel 2025
Annual Report (ESEF) Classification · 100% confidence FY 2025
2026-04-30 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.